Sunday , January 19 2020
Home / TECHNOLOGY / ArcherDX Personalized Cancer Monitoring (PCM) Technology Designated by FDA as Breakthrough Device

ArcherDX Personalized Cancer Monitoring (PCM) Technology Designated by FDA as Breakthrough Device

/PRNewswire/ — ArcherDX, Inc., today announced it has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its…
Source link

About fxncc

Check Also

Local company cashing in on new retail selling trend

As retailers obsess over ways to improve consumer experience in brick-and-mortar stores, West Carrol… Source …